Skip to main content
. 2011 Apr;71(4):536–543. doi: 10.1111/j.1365-2125.2010.03883.x

Figure 3.

Figure 3

Simulated median efavirenz steady-state AUC with and without concomitant rifampicin grouped according to bodyweight and CYP2B6 phenotype. The open bars are the median efavirenz steady-state AUC without concomitant rifampicin. The shaded bars are the median efavirenz steady-state AUC when co-administered with rifampicin. Abbreviations: EFV, efavirenz; EM, extensive CYP2B6 metabolizers; SM, slow CYP2B6 metabolizers